跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xantor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xantor
Approved
STANDARD
Xantor
Lek S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e40edcefcc1e379b
Company
Lek S.A.
Type
Standard
Approval Details
Approval Id
e40edcefcc1e379b
Drug Approval Philippines Name
Xantor
Product Name
Xantor
Registration Number
DRP-15499
Brand Name
Xantor
Generic Name
Atorvastatin (as calcium trihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Lek S.A.
Importer
Sandoz Philippines Corporation
Issuance Date
29 July 2024
Expiry Date
29 July 2029
Pharmacologic Category
HMG COA Reductase Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e40edcefcc1e379b
Type
Standard
Back to Philippines FDA Approvals